This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Exprivia Past Earnings Performance

Past criteria checks 3/6

Exprivia's earnings have been declining at an average annual rate of -8.9%, while the IT industry saw earnings growing at 20.3% annually. Revenues have been declining at an average rate of 24.9% per year. Exprivia's return on equity is 13.9%, and it has net margins of 6.7%.

Key information

-8.9%

Earnings growth rate

-9.8%

EPS growth rate

IT Industry Growth24.9%
Revenue growth rate-24.9%
Return on equity13.9%
Net Margin6.7%
Next Earnings Update06 Aug 2024

Recent past performance updates

Recent updates

Exprivia (BIT:XPR) Is Doing The Right Things To Multiply Its Share Price

Nov 18
Exprivia (BIT:XPR) Is Doing The Right Things To Multiply Its Share Price

Is It Time To Consider Buying Exprivia S.p.A. (BIT:XPR)?

Sep 23
Is It Time To Consider Buying Exprivia S.p.A. (BIT:XPR)?

A Look At The Intrinsic Value Of Exprivia S.p.A. (BIT:XPR)

Aug 30
A Look At The Intrinsic Value Of Exprivia S.p.A. (BIT:XPR)

Exprivia (BIT:XPR) Shareholders Will Want The ROCE Trajectory To Continue

Aug 10
Exprivia (BIT:XPR) Shareholders Will Want The ROCE Trajectory To Continue

What Is Exprivia S.p.A.'s (BIT:XPR) Share Price Doing?

Jun 14
What Is Exprivia S.p.A.'s (BIT:XPR) Share Price Doing?

Exprivia S.p.A.'s (BIT:XPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Apr 04
Exprivia S.p.A.'s (BIT:XPR) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Mar 01
Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Exprivia (BIT:XPR) Is Looking To Continue Growing Its Returns On Capital

Feb 02
Exprivia (BIT:XPR) Is Looking To Continue Growing Its Returns On Capital

Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Nov 11
Does Exprivia (BIT:XPR) Have A Healthy Balance Sheet?

Exprivia (BIT:XPR) Takes On Some Risk With Its Use Of Debt

Jul 08
Exprivia (BIT:XPR) Takes On Some Risk With Its Use Of Debt

Should You Investigate Exprivia S.p.A. (BIT:XPR) At €1.32?

Jun 10
Should You Investigate Exprivia S.p.A. (BIT:XPR) At €1.32?

Revenue & Expenses Breakdown

How Exprivia makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BIT:XPR Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231971300
30 Sep 231951300
30 Jun 231861200
31 Mar 231831200
31 Dec 221781200
30 Sep 221871100
30 Jun 221841100
31 Mar 221811100
31 Dec 211791000
30 Sep 211701000
30 Jun 21168900
31 Mar 21166800
31 Dec 20164900
30 Sep 20-9916400
30 Jun 20-57800
31 Mar 20987700
31 Dec 191657010
30 Sep 19567-82-50
30 Jun 19579440
31 Mar 19607860
31 Dec 18615000
30 Sep 18473-590
30 Jun 18367-750
31 Mar 18235-1240
31 Dec 17160040
30 Sep 17153-140
30 Jun 17148240
31 Mar 17144440
31 Dec 16140340
30 Sep 16139540
30 Jun 16137470
31 Mar 16139440
31 Dec 15141540
30 Sep 15146450
30 Jun 15148410
31 Mar 15147440
31 Dec 14144450
30 Sep 14137350
30 Jun 14135350
31 Mar 14130250
31 Dec 13128250
30 Sep 13131360

Quality Earnings: XPR has high quality earnings.

Growing Profit Margin: XPR's current net profit margins (6.7%) are higher than last year (6.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: XPR's earnings have declined by 8.9% per year over the past 5 years.

Accelerating Growth: XPR's earnings growth over the past year (13.9%) exceeds its 5-year average (-8.9% per year).

Earnings vs Industry: XPR earnings growth over the past year (13.9%) did not outperform the IT industry 26%.


Return on Equity

High ROE: XPR's Return on Equity (13.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/18 20:51
End of Day Share Price 2024/07/16 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Exprivia S.p.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Fabrizio SpagnaAxia Financial Research
Andrea DevitaBanca Akros S.p.A. (ESN)
Laura CarmignaniIntesa Sanpaolo Equity Research